Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

PLXND1 – Moebius syndrome

Moebius syndrome (MBS) is characterized by congenital facial and abducens nerve palsies. In a single MBS patient, fine mapping of a complex germline chromothriptic rearrangement revealed truncation of one allele of PLXND1, encoding the plexin-D1 receptor essential for semaphorin signaling, suggesting a role in cranial nerve development (PMID:31033088).

No additional pathogenic PLXND1 variants or familial segregations have been described in larger MBS cohorts, and no functional assays specifically assessing PLXND1 variants in MBS models have been performed. The limited genetic and experimental data thus restrict the clinical validity of PLXND1 in MBS to a “Limited” level.

Key take-home: While a single truncating PLXND1 lesion implicates plexin-D1 in MBS, further replication and functional studies are required before clinical implementation.

References

  • Human Mutation • 2019 • Multigenic truncation of the semaphorin-plexin pathway by a germline chromothriptic rearrangement associated with Moebius syndrome. PMID:31033088

Evidence Based Scoring (AI generated)

Gene–Disease Association

Limited

Single proband with truncating PLXND1 variant and no additional supporting cases.

Genetic Evidence

Limited

One proband with truncating PLXND1 from chromothripsis (PMID:31033088).

Functional Evidence

Limited

No functional studies in MBS context; pathogenicity inferred only from structural disruption.